Document is current
Any future updates will be listed below
-
Authors
Kohli, Jaskaren
Ge, Chen https://orcid.org/0000-0003-1758-747X
Fitsiou, Eleni https://orcid.org/0000-0002-5719-6345
Doepner, Miriam
Brandenburg, Simone M. https://orcid.org/0000-0001-6144-6194
Faller, William J. https://orcid.org/0000-0002-0738-2254
Ridky, Todd W. https://orcid.org/0000-0001-8482-1284
Demaria, Marco https://orcid.org/0000-0002-8429-4813
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding
- License Information
-
More Information
Article History
Received: 11 August 2022
Accepted: 16 December 2022
First Online: 23 December 2022
Competing interests
: M.D. is founder, shareholder, and advisor for Cleara Biotech and an advisor for Oisin Biotechnologies. Neither Cleara Biotech nor Oisin Biotechnologies were involved in the study. The remaining authors declare no other competing interests.
